# Intradermal Influenza Vaccine in the Young

> **NCT02103023** · PHASE3 · COMPLETED · sponsor: **The University of Hong Kong** · enrollment: 160 (actual)

## Conditions studied

- Influenza Viral Infections

## Interventions

- **DRUG:** Imiquimod ointment
- **DRUG:** Aqueous cream
- **BIOLOGICAL:** Intradermal influenza vaccine
- **BIOLOGICAL:** Intramuscular influenza vaccine

## Key facts

- **NCT ID:** NCT02103023
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2014-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02103023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02103023, "Intradermal Influenza Vaccine in the Young". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02103023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*